1.INTRODUCTION
The exocrine pancreas consists of two main types of cells: acinar and ductal cells.
Acinar cells secrete an isotonic, NaCl-rich fluid containing a multitude of enzymes and precursor enzymes. The precursor enzymes are activated in the small intestine, initiated by conversion of trypsinogen to trypsin by the intestinal enzyme enteropeptidase. Trypsin then activates trypsinogen autocatalytically and also consequently activates other precursors The major function of the pancreatic ductal cell is the secretion of an alkaline, HCO 3 -rich isotonic fluid, which serves two important functions: to flush digestive enzymes and toxic agents down the pancreatic ductal tree into the duodenum, and to help neutralize gastric acid.
Physiology of pancreatic ductal HCO 3 -and fluid secretion
The first step of HCO 3 -secretion is the accumulation of HCO 3 -inside the cell across the basolateral membrane of the duct cell by Na + /HCO 3 -co-transporters (NBC) and by the backward transport of protons via the Na + /H + exchanger (NHE) and an H + -ATPase. HCO 3 - secretion across the apical membrane of pancreatic ductal epithelial cells (PDEC) is thought to be mediated by anion channels and transporters such as cystic fibrosis transmembrane conductance regulator (CFTR) and solute carrier family 26 (SLC26) anion exchangers.
CFTR, a plasma-membrane cAMP-activated Cl -channel, is a member of the ATP binding cassette transporter superfamily. CFTR is expressed in numerous functionally diverse tissues, including the pancreas, kidney, intestine, sweat duct, heart and lung. In epithelial cells, CFTR mediates the secretion of Cl -. In addition to its role as a secretory Cl -channel, it also regulates several transport proteins, including the epithelial sodium channel, K + channels, ATP-release mechanisms, anion exchangers, sodium-bicarbonate transporters, and aquaporin water channels. CFTR has a PDZ-interacting domain, which mediates the binding of CFTR to several PDZ domain-containing proteins, including Na + /H + exchanger regulatory factor isoform-1 (NHERF-1).
NHERF-1 is a scaffolding protein that is involved in the apical targeting and trafficking of several membrane proteins and anchors them to the cytoskeleton via ezrin. NHERF-1 also facilitates the association of multiprotein complexes via PDZ and ezrin, radixin, moesinbinding domains, a process that is essential for the adequate transport and function of 
Pathophysiological role of pancreatic HCO 3 -secretion
Pancreatic ducts not only have prominent physiological, but also pathophysiological roles. Most studies of acute pancreatitis focus on the damage to acinar cells since they are assumed to be the primary target of multiple stressors affecting the pancreas. However, increasing evidence suggest that the ductal tree may have a crucial role in induction of the disease and is the primary target of stressors. Our hypothesis is that ductal secretion serves to defend the pancreas by washing out toxic agents such as bile acids, ethanol or activated trypsin. If this ductal defence mechanism is insufficient, ductal secretion will be inhibited and the harmful agents cannot leave the pancreas.
Trypsinogen is the most abundant digestive protease in the pancreas. Under physiological conditions, trypsinogen is synthesised and secreted by acinar cells, transferred to the duodenum via the pancreatic ducts and then activated by enteropeptidase in the small intestine. There is substantial evidence that early intra-acinar or luminal activation of trypsinogen to trypsin is a key and common event in the development of acute and chronic pancreatitis. Therefore, it is crucially important to understand the effects of trypsin on PDEC. 
AIMS
The main aims of this work were to investigate the physiology and pathophysiology of HCO 3 -and fluid secretion of PDEC.
Our specific aims were:
1. To evaluate the role of NHERF-1 in pancreatic ductal localization of CFTR, and in HCO 3 -and fluid secretion.
2. To investigate the effects of trypsin on pancreatic ductal HCO 3 -secretion.
Maintenance of animals and genotyping of NHERF-1 mice
The mice and guinea pigs were housed in a standard animal care facility with a 12-h light/12-h dark cycle and were allowed free access to water and standard laboratory chow.
NHERF-1-deficient mice were originally generated and described at Duke University Medical
Center. NHERF-1 mutation was congenic for the FVB/N background for at least 15
generations. Genotyping was performed by PCR.
Isolation and culture of pancreatic ducts
Mice and guinea pigs were humanly killed by cervical dislocation, the pancreas was removed and intra-/interlobular pancreatic ducts were isolated by enzymatic digestion, microdissection, and then they were cultured overnight at 37 °C in a humidified atmosphere containing 5% CO 2 . During overnight incubation, both ends of the isolated ducts seal and the ducts swell due to fluid secretion into the lumen. 
Western blot analysis
Western blot analysis was used to determine the specificity of the PAR-2 antibody.
Proteins were extracted from fresh-frozen guinea pig (n=3) and human (n=3) pancreatic tissue stored at -80 °C. Isolation was performed by using lysis buffer. Samples were homogenized, followed by centrifugation. Measurements of protein concentration were performed using Bradford-analysis. 30 μg of protein samples were loaded in each lane. Blots were incubated with polyclonal PAR-2 rabbit antibody and anti-GAPDH antibody at 4 °C overnight. After washing with 0.1% TRIS, horseradish peroxidise-conjugated anti-rabbit antibody was applied at room temperature. Signals were visualized by enhanced chemiluninescent detection.
Microperfusion and measurement of intracellular pH, Ca 2+ concentration
Intracellular pH (pH i ) and calcium concentration ([Ca 2+ ] i ) were estimated by microfluorimetry using the pH-and Ca 2+ -sensitive fluorescent dyes BCECF-AM and FURA 2-AM, respectively.
Measurement of fluid secretion

In vitro
Fluid secretion into the closed luminal space of the cultured pancreatic ducts was analysed using a swelling method. Briefly, the ducts were transferred to a perfusion chamber.
Bright-field images were acquired at 1 min intervals using a CCD camera. Digital images of the ducts were analysed using Scion Image software to obtain values for the area corresponding to the luminal space in each image.
In vivo
Mice were anesthetized with 1.5 g/kg urethane by i.p. injection. The abdomen was opened, and the lumen of the common biliopancreatic duct was cannulated with a blunt-end 30-gauge needle. Then the proximal end of the common duct was occluded with a microvessel clip to prevent contamination with bile, and the pancreatic juice was collected in PE-10 tube for 30 min. Using an operating microscope, the jugular vein was cannulated for administration of secretin (0.75 CU/kg) and the pancreatic juice was collected for an additional 120 min.
Intravital video microscopy
The experiment was performed to assess the possible consequences of secretin treatment on the microcirculation of the pancreas in anaesthetized mice with urethane. Using an operating microscope, the right jugular vein was cannulated for i.v. administration of secretin and the fluorescence marker used for the intravital microscopic examination. The animals were placed in a supine position on a heating pad and a midline laparotomy performed. The majority of the intestines were exteriorized to gain good assess to the pancreas which was carefully placed on a specially designed stage and covered with a microscopic cover slip. The microcirculation of the pancreas was visualized by intravital fluorescence microscopy using a single i.v. bolus of fluorescein isothiocyanate-labeled dextran. Video images of the microcirculatory network of the pancreatic tail were recorded at baseline and 20 min after the i.v. application of secretin. 
Statistical analysis
Pancreatic ductal HCO 3 -secretion is decreased in NHERF-1-knock-out mice
To determine if mislocalization of CFTR affects pancreatic ductal function, we investigated HCO 3 -secretion in isolated ducts using three different, but complementary, methods that measure the rate at which HCO 3 -is secreted across the luminal membrane via These data show that pancreatic ductal HCO 3 -secretion was significantly reduced in NHERF-1-KO compared to WT mice.
Fluid secretion is decreased in NHERF-1-knock-out mice
To investigate if fluid secretion was also compromised in KO mice, the rate of fluid secretion was measured. In the absence of secretagogue, we could not detect any significant changes in the volume of WT and NHERF-1-KO isolated pancreatic ducts. Stimulation of WT ducts with 5 µM forskolin caused dynamic swelling of the ducts as a result of fluid secretion into the closed luminal space. In contrast, ducts from NHERF-1-KO mice had a blunted response to forskolin.
We also examined the rate of pancreatic juice secretion in vivo in anesthetized mice.
Under basal conditions, WT animals secreted pancreatic juice at a rate of 0.12 ± 0.02 μl/hour/g body weight. In contrast, we could not detect any basal secretion in NHERF-1-KO animals. In response to secretin stimulation, we observed about 4-fold higher rates of pancreatic juice secretion in WT mice, values significantly higher than from NHERF-1-KO
mice. These results demonstrate that pancreatic fluid secretion was significantly reduced in NHERF-1-KO compared to WT animals under both basal and secretin-stimulated conditions.
Role of trypsin in pancreatic ductal HCO 3 -secretion 4.2.1. Expression of PAR-2 in guinea pig and human pancreata
PAR-2 was highly expressed in the luminal membrane of small intra-and interlobular ducts, but was almost undetectable in the larger interlobular ducts. The localization of PAR-2 in the human pancreas was identical to that in the guinea pig gland. Measurements of relative optical density confirmed the significant differences between the expression of PAR-2 in small intra-and interlobular ducts and the larger interlobular ducts in both species.
Luminal administration of PAR-2 activating peptide and trypsin induces dose-dependent intracellular calcium signalling
Since PAR-2 expression was detected only on the luminal membrane of intralobular duct cells, we used the microperfusion technique to see whether these receptors can be activated by PAR-2 agonists. First, the experiments were performed at pH 7. 
PAR-2 is down-regulated in patients suffering from chronic pancreatitis
It has been documented that there is activated trypsin in the pancreatic ductal lumen in chronic pancreatitis in human. If trypsin activity is elevated in the duct lumen, PAR-2 downregulation should occur. Our data show a marked reduction in membranous PAR-2 protein level, but no significant changes in cytoplasmic PAR-2 protein in chronic pancreatitis.
Furthermore, PAR-2 mRNA level was markedly reduced in chronic pancreatitis, suggesting that reduced PAR-2 mRNA transcription may cause PAR-2 down-regulation in chronic pancreatitis.
Luminal exposure to R122H mutant cationic trypsin induces elevation of intracellular calcium concentration and evokes alkalosis in PDEC
It has been demonstrated that mutations in cationic trypsinogen increase the risk of 
Activation of PAR-2 is diminished in PAR-2 KO mice
Finally, we investigated the effects of both PAR-2-AP and trypsin on PDEC isolated from WT and PAR-2 KO mice. First we confirmed using immunohistochemistry that WT mice do, whereas PAR-2 KO mice do not express PAR-2 in their PEDC. Accordingly, our functional data clearly show that the pH i and [Ca 2+ ] i responses to luminal administration of either trypsin or PAR-2-AP were markedly diminished in PAR-2 KO PDEC.
DISCUSSION
The effect of NHERF-1 on pancreatic ductal HCO 3 -secretion
We have demonstrated that NHERF-1 mRNA is highly expressed in mouse pancreatic There are important species differences regarding the localization of PAR-2 in pancreatic ducts and in the effect of PAR-2 activation on HCO 3 -secretion. For example, CAPAN-1 cells and dog PDEC express PAR-2 only on the basolateral membrane, whereas bovine PDEC express PAR-2 on the luminal membrane. Therefore, one of our aims was to determine which animal model best mimics human PAR-2 expression and thus would be the best for studying the effects of trypsin on PDEC function. Our results showed that in the human pancreas PAR-2 is localized to the luminal membrane of small proximal pancreatic ducts, which are probably the major site of HCO 3 -and fluid secretion. Since PAR-2 expression in the guinea pig pancreas was localized to the luminal membrane of duct cells, we performed our experiments on isolated guinea pig ducts.
First we characterized the effects of PAR-2 activation by trypsin and PAR-2-AP on PDEC. Previously, it has been shown that activation of the G-protein-coupled PAR-2 by proteinases requires proteolytic cleavage of the receptor, which is followed by an elevation of Receptor down-regulation is a phenomenon that occurs in the continued presence of an agonist and leads to a reduction in the cell's sensitivity to the agonist. In this study, we provide evidence that transcriptional down-regulation explains the reduced expression of PAR-2 seen in chronic pancreatitis.
In conclusion, we suggest for the first time that one of the physiological roles of 
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